| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0753-3322(99)80118-8 |
| P698 | PubMed publication ID | 10554674 |
| P2093 | author name string | Meier CR | |
| P2860 | cites work | Association between dental health and acute myocardial infarction | Q24675367 |
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Validation of information recorded on general practitioner based computerised data resource in the United Kingdom | Q33539292 | ||
| Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies | Q33776566 | ||
| The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
| Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. | Q35559048 | ||
| In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae | Q35885610 | ||
| Helicobacter pylori infection and coagulation in healthy people | Q36244133 | ||
| Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population | Q36244159 | ||
| Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study | Q36244426 | ||
| Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study | Q36247009 | ||
| The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987. | Q36506125 | ||
| Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class | Q36824852 | ||
| Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? | Q36832379 | ||
| Infection as a risk factor for infarction and atherosclerosis | Q36845622 | ||
| Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline | Q37093492 | ||
| Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications | Q37214056 | ||
| Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR | Q37243062 | ||
| Excess deaths attributable to influenza in England and Wales: age at death and certified cause | Q57140688 | ||
| Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease | Q58475992 | ||
| Acute myocardial infarction precipitated by infectious disease | Q70714470 | ||
| Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients | Q71267194 | ||
| Human cytomegalovirus and restenosis of the internal carotid artery | Q71477340 | ||
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
| Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils | Q71935621 | ||
| In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation | Q74071849 | ||
| The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe | Q74152265 | ||
| Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk | Q74501639 | ||
| The UK General Practice Research Database | Q77357717 | ||
| Association of Helicobacter pylori infection with elevated serum lipids | Q77910810 | ||
| Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability | Q37361893 | ||
| Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study | Q37878617 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease | Q37878785 | ||
| Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction | Q37878896 | ||
| Chlamydia infections and heart disease linked through antigenic mimicry | Q37878963 | ||
| Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts | Q37879001 | ||
| Antibiotics and risk of subsequent first-time acute myocardial infarction | Q37879181 | ||
| Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension | Q37879204 | ||
| C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes | Q37879244 | ||
| In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries. | Q37880155 | ||
| Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis | Q37880332 | ||
| Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. | Q37881308 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up | Q37881662 | ||
| Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis | Q37881850 | ||
| Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement | Q37883688 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
| Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy | Q37885296 | ||
| The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in Finland | Q37886297 | ||
| Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 | ||
| Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture | Q37887150 | ||
| Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae | Q37888465 | ||
| Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis | Q37889646 | ||
| Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis | Q37890130 | ||
| Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease | Q37891247 | ||
| Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
| Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
| Persistent infection with Chlamydia pneumoniae following acute respiratory illness | Q37893923 | ||
| Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons | Q37895599 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections | Q37902805 | ||
| An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci | Q37904432 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Childhood living conditions and Helicobacter pylori seropositivity in adult life | Q41089349 | ||
| The role of heat shock proteins in protection and pathophysiology of the arterial wall | Q41181626 | ||
| Periodontal disease and cardiovascular disease | Q41204551 | ||
| The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus | Q41212001 | ||
| Relation of Helicobacter pylori infection and coronary heart disease | Q41333642 | ||
| Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? | Q41469163 | ||
| Alternative hypothesis for efficacy of macrolides in acute coronary syndromes | Q43429541 | ||
| Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection | Q43432916 | ||
| Acute respiratory-tract infections and risk of first-time acute myocardial infarction | Q43995973 | ||
| Viral and bacterial infections in patients with acute myocardial infarction | Q45004940 | ||
| Cytomegalovirus antigen within human arterial smooth muscle cells | Q45224814 | ||
| Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. | Q50866437 | ||
| Association of virulent Helicobacter pylori strains with ischemic heart disease. | Q50887983 | ||
| Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
| Seasonal Distribution of Acute Myocardial Infarction in the Second National Registry of Myocardial Infarction 11The National Registry of Myocardial Infarction is supported by Genentech, Inc., South San Francisco, California. Genentech, Inc. reimburse | Q56765301 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 397-404 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Biomedicine and Pharmacotherapy | Q15759648 |
| P1476 | title | The possible role of infections in acute myocardial infarction | |
| P478 | volume | 53 |
| Q35793997 | Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012. |
| Q45130861 | Further evidence of the association between periodontal conditions and coronary artery disease |
| Q37602840 | Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review |
| Q36453962 | Influenza epidemics, seasonality, and the effects of cold weather on cardiac mortality |
| Q41864650 | Myocardial infarction associated with pseudoephedrine use and acute streptococcal infection in a boy with normal coronary arteries |
| Q54569157 | Streptococcus sanguinis-induced cytokine release from platelets. |
| Q30620826 | The impact of the February 2012 cold spell on health in Italy using surveillance data |
Search more.